Getagraph.com logo
S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.93%) $83.07
Gas
(-1.16%) $1.619
Gold
(-0.33%) $2 339.50
Silver
(-0.05%) $27.52
Platinum
(0.50%) $926.70
USD/EUR
(-0.16%) $0.933
USD/NOK
(-0.13%) $11.01
USD/GBP
(-0.24%) $0.798
USD/RUB
(0.00%) $92.17

Realaus laiko atnaujinimai BioPharma Credit PLC [BPCR.L]

Birža: LSE Pramonė: Diversified Financials
Atnaujinta26 bal. 2024 @ 19:10
25% discount on Stockinvest.us - Use code: Podcast

0.23% $ 0.878

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 19:10):
Profile picture for BioPharma Credit PLC

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products...

Stats
Šios dienos apimtis 1.61M
Vidutinė apimtis 1.72M
Rinkos kapitalizacija 10.79M
EPS $0 ( 2024-03-27 )
Kita pelno data ( $0 ) 2024-06-12
Last Dividend $0.0175 ( 2023-08-17 )
Next Dividend $0 ( N/A )
P/E 10.98
ATR14 $0.00100 (0.11%)

BioPharma Credit PLC Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

BioPharma Credit PLC Finansinės ataskaitos

Annual 2023
Pajamos: $110.49M
Bruto pelnas: $110.49M (100.00 %)
EPS: $0.0828
FY 2023
Pajamos: $110.49M
Bruto pelnas: $110.49M (100.00 %)
EPS: $0.0828
FY 2022
Pajamos: $184.25M
Bruto pelnas: $184.25M (100.00 %)
EPS: $0.130
FY 2021
Pajamos: $87.97M
Bruto pelnas: $0.00 (0.00 %)
EPS: $0.0620

Financial Reports:

No articles found.

BioPharma Credit PLC Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.0175
(N/A) 		$0.0450
(N/A) 		$0.0158
(N/A) 		$0.0175
(N/A) 		$0.0175
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A)

BioPharma Credit PLC Dividend Information - Dividend Knight

Dividend Sustainability Score: 7.79 - good (77.86%) | Divividend Growth Potential Score: 4.24 - Stable (15.22%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0100 2017-09-28
Last Dividend $0.0175 2023-08-17
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 25 --
Total Paid Out $0.385 --
Avg. Dividend % Per Year 1.46% --
Score 4.14 --
Div. Sustainability Score 7.79
Div.Growth Potential Score 4.24
Div. Directional Score 6.01 --
Next Divdend (Est)
 (2024-07-01)
$0.0175 Estimate 21.90 %
Dividend Stability
0.58 Average
Dividend Score
4.14
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2017 $0.0200 0.02%
2018 $0.0594 0.06%
2019 $0.0543 0.05%
2020 $0.0479 0.05%
2021 $0.0554 0.06%
2022 $0.0975 0.10%
2023 $0.0508 5.35%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for LSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SUPR.L Dividend Knight 2023-07-13 Quarterly 8 3.25%
KEYS.L Dividend Knight 2023-09-21 Annually 7 2.29%
CCJI.L Dividend Knight 2023-07-06 Semi-Annually 9 2.14%
QXT.L Ex Dividend Junior 2023-07-27 Sporadic 11 0.46%
GHH.L Dividend Knight 2023-06-22 Annually 27 0.91%
AMC.L Dividend Knight 2023-06-01 Insufficient data to determine frequency 2 55.57%
TPFG.L Dividend Knight 2023-09-21 Annually 11 3.16%
MACF.L Dividend King 2023-09-14 Semi-Annually 32 1.94%
CREI.L Dividend Knight 2023-07-20 Quarterly 11 3.34%
RUR.L Dividend Knight 2023-06-22 Sporadic 20 10.67%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.7991.50010.0010.00[0 - 0.5]
returnOnAssetsTTM0.07991.2007.348.80[0 - 0.3]
returnOnEquityTTM0.08131.500-0.208-0.312[0.1 - 1]
payoutRatioTTM0.828-1.0001.722-1.722[0 - 1]
currentRatioTTM9.790.80010.008.00[1 - 3]
quickRatioTTM9.780.80010.008.00[0.8 - 2.5]
cashRatioTTM8.511.50010.0010.00[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM0.09462.009.9710.00[0 - 30]
freeCashFlowPerShareTTM0.09462.009.9510.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM1.0001.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.7991.00010.0010.00[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM0.1000.800-2.67-2.13[0.5 - 2]
Total Score7.79

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM10.551.0009.040[1 - 100]
returnOnEquityTTM0.08132.50-0.134-0.312[0.1 - 1.5]
freeCashFlowPerShareTTM0.09462.009.9710.00[0 - 30]
dividendYielPercentageTTM11.631.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM0.09462.009.9710.00[0 - 30]
payoutRatioTTM0.8281.5001.722-1.722[0 - 1]
pegRatioTTM-0.3891.500-5.930[0.5 - 2]
operatingCashFlowSalesRatioTTM0.9081.00010.000[0.1 - 0.5]
Total Score4.24

BioPharma Credit PLC

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.